A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LRFS / local recurrence-free survival

[Related PubMed/MEDLINE]
Total Number of Papers: 539
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LRFS  (>> Co-occurring Abbreviation)
Long Form:   local recurrence-free survival
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma. DMFS, IDC, IDLC, ILC
2020 Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. BED, dCCRT, ESCC, OS
2020 Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection. ACT, DFS, DMFS, LARC, OS, pCR
2020 Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis. AEs, CCRT, DRFS, NCT, NPC, OS, PLNC, PSM, RFS
2020 Combined neat model for the prognosis of postoperative stage III-N2 non-small cell lung cancer. CA125, CEA, DMFS, NSCLC, OS, PFS
2020 Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level. DMFS, OS, PFS
2020 Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non-small cell lung cancer: Updated follow-up results from two phase II trials. CCRT, DMFS, NSCLC, OS, PFS
2020 Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial. CME, NCME
2020 Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial. BCS, DFS, DMFS, ET, HR, IBRs, OS, WBI
10  2020 Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases. DMFS, NPC, OS, PFS, PLN
11  2020 Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma. CI, DMeFS, DSS, GO, HR, NPC
12  2020 Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome. AJCC, DMFS, DSS, MTC
13  2020 High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy. CCRT, DSS, EREG, MeFS
14  2020 Hypofractionated radiation therapy with versus without immune checkpoint inhibitors in patients with brain metastases: A meta-analysis. BM, HFRT, ICIs, mOS, OS
15  2020 Impact of Paranasal Sinus Invasion on Oncologic and Dosimetric Outcomes in Nasopharyngeal Carcinoma Following Intensity-Modulated Radiation Therapy-Implications for Risk Stratification and Planning Optimization. IMRT, NPC, PSI
16  2020 Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival. DFS, NAC, OS, pCR
17  2020 Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer. DFS, LRRC, MFS, OS
18  2020 Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence. ER, IBTR, IQR, OS, PR
19  2020 Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy? BC, NAC, OS, PMRT, PSM, RFS
20  2020 KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases. CRLM, mutKRAS, OS
21  2020 Long-term results from a series of patients managed with breast conservation surgery and hypofractionated radiotherapy in Christchurch: What is the recurrence rate and how do we detect recurrences. BCS, CFRT, Gy, HFRT, LRR, OS
22  2020 Long-Term Survival After Nasopharyngeal Carcinoma Treatment in a Local Prefecture-Level Hospital in Southern China. DMFS, IMRT, OS, RRFS, ZSPH
23  2020 Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy. CCRT
24  2020 Machine Learning Analysis of Image Data Based on Detailed MR Image Reports for Nasopharyngeal Carcinoma Prognosis. AJCC, AutoML, DMFS, KM, MR, NPC, OS, PFS, ROC, TNM
25  2020 Management of orbital invasion in sinonasal squamous cell carcinoma: 15 years' experience. DMFS, OS, PFS, SNSCCs
26  2020 Multicenter study of surgical and oncologic outcomes of extra-levator versus conventional abdominoperineal excision for lower rectal cancer. APE, DFS, ELAPE, OS
27  2020 Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma. AT, DDFS, DFS, HR, ICB, MSS, NAT, pCR, pPR
28  2020 Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein-Barr virus DNA level after induction chemotherapy. CCD, CCRT, EBV, IC
29  2020 Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol. OS, VDC-IE
30  2020 Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer. PFS, SBRT
31  2020 Perineural invasion predicts for locoregional failure in patients with oesophageal adenocarcinoma treated with neoadjuvant chemoradiotherapy. DFS, nCRT, PNI
32  2020 Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study. NSCLC, OS, POCT, PORT
33  2020 Postoperative radiotherapy for the young-old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience. DFS, DMFS, KPS, OS, PORT, TESCC
34  2020 Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1. mTOR, p-S6K1
35  2020 Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases. CLM, CSS, CT, DFS, F-FDG, MTV, OS, TLG
36  2020 Primary aneurysmal bone cysts. ABC, CI
37  2020 Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy. DFS, OPSCC, OS, PET/CT
38  2020 Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma. DMFS, ONBs, OS, PFS, RT
39  2020 Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count. DMFS, HR, IMRT, PFS, RIL
40  2020 Redefining adequate margins in oral squamous cell carcinoma: outcomes from close and positive margins. DFS, OS
41  2020 Retroperitoneal soft-tissue sarcomas: Radiotherapy experience from a tertiary cancer center and review of current evidence. DFS, DMFS, OS, PORT, PrORT, RPS
42  2020 Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan. ---
43  2020 Role of adjuvant (chemo)radiotherapy for resected extrahepatic cholangiocarcinoma: a meta-analysis. ACRT, ART, CI, DFS, EHCC, HRs, OS, RCTs
44  2020 Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results. CRT, CSS, DMFS, HNSCC, IC
45  2020 Stereotactic body radiation therapy for early-stage non-small-cell lung cancer in octogenarians and older: an alternative treatment. CRP, CSS, NSCLC, OS, PFS, RRFS, SBRT
46  2020 Stratification of Candidates for Induction Chemotherapy in Stage III-IV Nasopharyngeal Carcinoma: A Large Cohort Study Based on a Comprehensive Prognostic Model. CCRT, DMFS, EBV, IC, IMRT, LDH, NPC, OS, PFS, PI
47  2020 Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study. HR, MFS, MPTs, OS, SS
48  2020 Survival ofstage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study. CCRT, CCT, DMFS, IMRT, NPC, OS, PFS, RT
49  2020 The endoscopic endonasal approach for sinonasal and nasopharyngeal adenoid cystic carcinoma. DFS, DMFS, EEA, OS, RT, SNACC
50  2020 The Impact of Surgical Margins and Adjuvant Radiotherapy in Patients with Undifferentiated Pleomorphic Sarcomas of the Extremities: A Single-Institutional Analysis of 192 Patients. OS
51  2020 The relevance of surgical margins in clinically early oral squamous cell carcinoma. C-T, DFS, DSS, HR, INC-T, OS, OSCC
52  2020 Treatment effects of cumulative cisplatin dose during radiotherapy following induction chemotherapy in nasopharyngeal carcinoma: propensity score analyses. CCD, DMFS, IC, NPC, OS, RT
53  2020 Two-year outcome of concurrent chemoradiation with carboplatin with or without adjuvant carboplatin/fluorouracil in nasopharyngeal cancer: A multicenter randomized trial. AC, CCRT, DFS, DMFS, NPC, OS
54  2020 Wound complications are a predictor of worse oncologic outcome in extremity soft tissue sarcomas. DSS, MFS
55  2020 YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma. dCRT, ESCC, HR, OS, PFS
56  2020 [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy]. cCR, CCRT, DMFS, IMRT, LARC, LRR, nCRT, OS, SPR, TME
57  2019 A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis. CI, DMFS, HNC, HR, IMRT, OS, PFS, SEQ, SIB
58  2019 A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma. CCRT, CI, CTX, DFS, DMFS, HRs, NPC, OS
59  2019 A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors. CCRT, GIT, OS
60  2019 A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma. CCT, CI, DFS, ESCC, HR, OS
61  2019 Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study. CSS, DMFS, UTUC
62  2019 Assessment of the effect of the Aquamantys system on local recurrence after hepatectomy for hepatocellular carcinoma through propensity score matching. MVI, RFS
63  2019 Association of Chemoradiotherapy Regimens and Survival Among Patients With Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis. AC, CCRT, DMFS, HR, IC, NPC, OS, PFS, TSA
64  2019 Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma. CRT, GB, OS, RFS
65  2019 Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS. DRFS
66  2019 Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan. DF
67  2019 Clinicopathological implications of TIM3+ tumor-infiltrating lymphocytes and the miR-455-5p/Galectin-9 axis in skull base chordoma patients. Gal9, KPS, OS, TIL, TIM3
68  2019 Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer. BCSS, DFS, DM, DMFS, LRR, PSM, RT
69  2019 Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk. DFS, DMFS, IMRT, OS, STS
70  2019 Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma. CCRT, DFS, DMFS, NPC, OS
71  2019 Defining optimum surgical margins in buccoalveolar squamous cell carcinoma. ---
72  2019 Definitive radiotherapy or chemoradiotherapy for distal rectal cancer with early stage of cT1-2N0. cCR, DMFS, OS, PFS
73  2019 Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan. DCA, DMFS, DSS, STSs
74  2019 Differential effect of concurrent chemotherapy regimen on clinical outcomes of preoperative chemoradiotherapy for locally advanced rectal cancer. 5-FU, CRT, DFS, DMFS, OS
75  2019 Does Clearance of Positive Margins Improve Local Control in Oral Cavity Cancer? A Meta-analysis. FS, HR, IPD, LR, OCC, PRISMA
76  2019 Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma? BCLC, GyE, HCC, mUICC, OS, PBT, PTV1
77  2019 Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes. CF, CSS, FC, LN, NRT
78  2019 HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer. AE, DMFS, EP, NSCLC, OS, PFS
79  2019 High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes. bPFS, EBRT, GI, GU, HDR-BT, HS, MFS, OS, TURP
80  2019 High-Dose Thoracic Re-irradiation of Lung Cancer Using Highly Conformal Radiotherapy Is Effective with Acceptable Toxicity. BED10, OS, re-RT
81  2019 Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression. CCRT, DSS, HR, MeFS
82  2019 Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma. AJCC, C-indices, CI, DRFS, HPV, HR, OS, SCC
83  2019 Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma. ALN, BC, HR, IDC-NST, LVI, SLN
84  2019 Impact of primary tumor location on outcome of liposarcoma patients, a retrospective cohort study. DMFS, DSS, LPS
85  2019 IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study. CCRT, DMFS, IMRT, LANPC, OS, PFS
86  2019 Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. DFS, DMFS, LARC, LNs, LNY, neo-CRT, OS, TRG
87  2019 Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort. AUC, CCRT, CCT, DMFS, EBV, IMRT, NPC, OS, PFS
88  2019 KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients. CTC, DMFS, OS, RT-qPCR
89  2019 Leiomyosarcoma: Clinicopathological study and retrospective analysis of prognostic factors in a series of 100 patients. LMS, MFS, OS
90  2019 Local Radiotherapy or Chemotherapy for Oligo-recurrent Cervical Cancer in Patients With Prior Pelvic Irradiation. DFS, OS
91  2019 Long-term Outcome of 181 Patients With Liposarcomas of the Extremity and Truncal Wall. LS, OS
92  2019 Long-term outcomes of high-dose single-fraction radiosurgery for chordomas of the spine and sacrum. OS, SRS
93  2019 Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma. BT, CMT, DFS, EBRT, OS, rNPC
94  2019 MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma. DFS, DMFS, MRI, NMF, NPC, OS
95  2019 Negative Impact of Wound Complications on Oncologic Outcome of Soft Tissue Sarcomas of the Chest Wall. DSS, MFS
96  2019 Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone. GCTB
97  2019 Neoadjuvant radiotherapy followed by surgery compared with surgery alone in the treatment of retroperitoneal sarcoma: a population-based comparison. nrt, OS, rps
98  2019 Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer. CCRT, DMFS, OS, RRFS
99  2019 Outcomes of stage II-IV upper-tract urothelial carcinoma and adjuvant chemotherapy for locally advanced cancer. CI, DFS, DMFS, HR, OS, UTUC
100  2019 Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis. CSS, NSCLC, OS, PSM, RFS, SBRT